loading

Intensity Therapeutics Inc Azioni (INTS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
20.30%
2.705
3.394 3.203 3.57 5.069
Operating Income/Loss
20.30%
-2.705
-3.394 -3.203 -3.57 -5.069
Income/Loss From Continuing Operations Before Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Income/Loss From Continuing Operations After Tax
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Net Income/Loss
24.20%
-2.537
-3.347 -3.181 -3.513 -4.971
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Diluted Average Shares
24.35%
18.87
15.17 0.1646 13.80 13.71
Basic Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Diluted Earnings Per Share
40.91%
-0.13
-0.22 -0.22 -0.25 -0.36
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.49
price up icon 0.86%
$31.73
price down icon 0.95%
$102.94
price up icon 2.50%
$96.03
price up icon 0.03%
biotechnology ONC
$316.12
price down icon 4.75%
$205.64
price up icon 0.29%
Capitalizzazione:     |  Volume (24 ore):